These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 26344578)
1. The impact of opioid-induced constipation among chronic pain patients with sufficient laxative use. LoCasale RJ; Datto CJ; Margolis MK; Tack J; Coyne KS Int J Clin Pract; 2015 Dec; 69(12):1448-56. PubMed ID: 26344578 [TBL] [Abstract][Full Text] [Related]
2. Opioid-Induced Constipation Among Patients with Chronic Noncancer Pain in the United States, Canada, Germany, and the United Kingdom: Laxative Use, Response, and Symptom Burden Over Time. Coyne KS; Margolis MK; Yeomans K; King FR; Chavoshi S; Payne KA; LoCasale RJ Pain Med; 2015 Aug; 16(8):1551-65. PubMed ID: 25802051 [TBL] [Abstract][Full Text] [Related]
3. Laxative utilization over time in chronic pain patients with opioid-induced constipation. Datto CJ; LoCasale RJ; Margolis MK; Thompson CL; Coyne KS Pain Manag; 2016 Nov; 6(6):531-541. PubMed ID: 27476539 [TBL] [Abstract][Full Text] [Related]
4. The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports. LoCasale RJ; Datto C; Wilson H; Yeomans K; Coyne KS J Manag Care Spec Pharm; 2016 Mar; 22(3):236-45. PubMed ID: 27003553 [TBL] [Abstract][Full Text] [Related]
5. Opioid-induced constipation, use of laxatives, and health-related quality of life. Christensen HN; Olsson U; From J; Breivik H Scand J Pain; 2016 Apr; 11():104-110. PubMed ID: 28850447 [TBL] [Abstract][Full Text] [Related]
6. Satisfaction with Therapy Among Patients with Chronic Noncancer Pain with Opioid-Induced Constipation. LoCasale RJ; Datto C; Margolis MK; Coyne KS J Manag Care Spec Pharm; 2016 Mar; 22(3):246-53. PubMed ID: 27003554 [TBL] [Abstract][Full Text] [Related]
7. Treatment with prolonged-release oxycodone/naloxone improves pain relief and opioid-induced constipation compared with prolonged-release oxycodone in patients with chronic severe pain and laxative-refractory constipation. Poelaert J; Koopmans-Klein G; Dioh A; Louis F; Gorissen M; Logé D; Van Op den Bosch J; van Megen YJ Clin Ther; 2015 Apr; 37(4):784-92. PubMed ID: 25757607 [TBL] [Abstract][Full Text] [Related]
8. Opioid-Induced Constipation among a Convenience Sample of Patients with Cancer Pain. Coyne KS; Sexton C; LoCasale RJ; King FR; Margolis MK; Ahmedzai SH Front Oncol; 2016; 6():131. PubMed ID: 27376025 [TBL] [Abstract][Full Text] [Related]
9. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK. Lawson R; Ryan J; King F; Goh JW; Tichy E; Marsh K Pharmacoeconomics; 2017 Feb; 35(2):225-235. PubMed ID: 27663572 [TBL] [Abstract][Full Text] [Related]
10. Assessment of a Stool Symptom Screener and Understanding the Opioid-Induced Constipation Symptom Experience. Coyne KS; Currie BM; Holmes WC; Crawley JA Patient; 2015 Aug; 8(4):317-27. PubMed ID: 25231829 [TBL] [Abstract][Full Text] [Related]
11. Fixed ratio (2:1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives. Koopmans G; Simpson K; De Andrés J; Lux EA; Wagemans M; Van Megen Y Curr Med Res Opin; 2014 Nov; 30(11):2389-96. PubMed ID: 25265132 [TBL] [Abstract][Full Text] [Related]
12. Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review. Coyne KS; LoCasale RJ; Datto CJ; Sexton CC; Yeomans K; Tack J Clinicoecon Outcomes Res; 2014; 6():269-81. PubMed ID: 24904217 [TBL] [Abstract][Full Text] [Related]
13. Laxative management in ambulatory cancer patients on opioid therapy: a prospective, open-label investigation of polyethylene glycol, sodium picosulphate and lactulose. Wirz S; Nadstawek J; Elsen C; Junker U; Wartenberg HC Eur J Cancer Care (Engl); 2012 Jan; 21(1):131-40. PubMed ID: 21880080 [TBL] [Abstract][Full Text] [Related]
14. Impact of constipation on opioid therapy management among long-term opioid users, based on a patient survey. Gupta S; Patel H; Scopel J; Mody RR J Opioid Manag; 2015; 11(4):325-38. PubMed ID: 26312960 [TBL] [Abstract][Full Text] [Related]
15. Laxatives Do Not Improve Symptoms of Opioid-Induced Constipation: Results of a Patient Survey. Emmanuel A; Johnson M; McSkimming P; Dickerson S Pain Med; 2017 Oct; 18(10):1932-1940. PubMed ID: 28339544 [TBL] [Abstract][Full Text] [Related]
16. Optimal treatment of opioid induced constipation in daily clinical practice - an observational study. Neefjes ECW; van der Wijngaart H; van der Vorst MJDL; Ten Oever D; van der Vliet HJ; Beeker A; Rhodius CA; van den Berg HP; Berkhof J; Verheul HMW BMC Palliat Care; 2019 Mar; 18(1):31. PubMed ID: 30922276 [TBL] [Abstract][Full Text] [Related]
17. Inadequate management of opioid-induced constipation in European cancer pain patients: results of a real-world, multicentre, observational study ("E-StOIC"). Davies A; Fagan N; Gonzalez-Barboteo J; Chelazzi C; Economos G; Elsner F; Leach C; Monsen RE; Oldenmenger WH; Remi C; van den Beuken-van Everdingen M; Wüstefeld M Support Care Cancer; 2024 Oct; 32(10):701. PubMed ID: 39367106 [TBL] [Abstract][Full Text] [Related]
18. Patients' Self-Assessment of the Symptoms and Impact of Opioid-Induced Constipation: Results From a Prospective Observational Cohort Study of Japanese Patients With Cancer. Fumita S; Imai H; Harada T; Noriyuki T; Gamoh M; Akashi Y; Sato H; Kizawa Y; Tokoro A J Pain Symptom Manage; 2020 May; 59(5):1043-1051.e2. PubMed ID: 31805362 [TBL] [Abstract][Full Text] [Related]
19. Lubiprostone vs Senna in postoperative orthopedic surgery patients with opioid-induced constipation: a double-blind, active-comparator trial. Marciniak CM; Toledo S; Lee J; Jesselson M; Bateman J; Grover B; Tierny J World J Gastroenterol; 2014 Nov; 20(43):16323-33. PubMed ID: 25473191 [TBL] [Abstract][Full Text] [Related]
20. Patient preference with respect to QoL and reduction in opioid-induced constipation (OIC) after treatment with prolonged-release (PR) oxycodone/naloxone compared with previous analgesic therapy [PREFER study]. van Dongen VC; Vanelderen PJ; Koopmans-Klein G; van Megen YJ; Van Zundert J; Huygen FJ Int J Clin Pract; 2014 Nov; 68(11):1364-75. PubMed ID: 24853258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]